{"id":746044,"date":"2023-04-07T01:03:04","date_gmt":"2023-04-07T05:03:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\/"},"modified":"2023-04-07T01:03:04","modified_gmt":"2023-04-07T05:03:04","slug":"innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\/","title":{"rendered":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023"},"content":{"rendered":"

<\/p>\n

Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023<\/b><\/p>\n

The Annual General Meeting will be broadcasted live by the Company<\/i><\/b><\/p>\n

MARSEILLE, France–(BUSINESS WIRE<\/a>)–
\nInnate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (\u201cInnate<\/b>\u201d or the \u201cCompany<\/b>\u201d) will hold its Annual General Meeting of Shareholders (\u201cAGM<\/b>\u201d) at 10:30 a.m. CEST on May 12, 2023 in its headquarters, 117 avenue de Luminy, F-13009 Marseille. The Annual General Meeting will be broadcasted live.<\/p>\n

\nThe Notice of Meeting of this AGM was published on April 7, 2023 in the French legal bulletin. It includes the agenda, the proposed resolutions as well as instructions to participate and vote in this AGM.<\/p>\n

\nAll documentation regarding this AGM will be published on the Company\u2019s website<\/a> along with the dial-in details for the live broadcast.<\/p>\n

Precision regarding the AGM:<\/b><\/p>\n

\nOnly shareholders having registered their shares at least two business days prior to the date of the AGM, by zero hour Paris time, will be able to participate.<\/p>\n

\nShareholders holding \u201cau porteur<\/i>\u201d (bearer) shares will need to obtain an \u201cattestation de participation<\/i>\u201d (certificate of shareholding) from their brokers. This \u201cattestation de participation<\/i>\u201d must be attached to the voting or proxy form.<\/p>\n

\nWritten questions from shareholders must be received the second business days prior to the AGM at the latest (by e-mail to investors@innate-pharma.fr<\/a>).<\/p>\n

\nShareholders may obtain the legal documentation in preparation of the AGM (as described in article R. 225-83 of the French Code de Commerce<\/i>) by sending a request by e-mail to investors@innate-pharma.fr<\/a>.<\/p>\n

About Innate Pharma<\/b><\/p>\n

\nInnate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Its innovative approach aims to harness the innate immune system through therapeutic antibodies and its ANKET\u00ae<\/sup> (A<\/b>ntibody-based NK<\/b> cell E<\/b>ngager T<\/b>herapeutics) proprietary platform.<\/p>\n

\nInnate\u2019s portfolio includes lead proprietary program lacutamab, developed in advanced form of cutaneous T cell lymphomas and peripheral T cell lymphomas, monalizumab developed with AstraZeneca in non-small cell lung cancer, as well as ANKET\u00ae<\/sup> multi-specific NK cell engagers to address multiple tumor types.<\/p>\n

\nInnate Pharma is a trusted partner to biopharmaceutical companies such as Sanofi and AstraZeneca, as well as leading research institutions, to accelerate innovation, research and development for the benefit of patients.<\/p>\n

\n

\nHeadquartered in Marseille, France with a US office in Rockville, MD, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.<\/p>\n

\nLearn more about Innate Pharma at www.innate-pharma.com<\/a> and follow us on Twitter<\/a> and LinkedIn<\/a>.<\/p>\n

Information about Innate Pharma shares<\/b><\/p>\n\n\n
\n

ISIN code
\n<\/b>
Ticker code
\n<\/b>
LEI<\/b><\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\nFR0010331421<\/p>\n

\nEuronext: IPH Nasdaq: IPHA<\/p>\n

\n9695002Y8420ZB8HJE29<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

Disclaimer on forward-looking information and risk factors<\/b><\/p>\n

\nThis press release contains certain forward-looking statements, including those within the meaning of the Private Securities Litigation Reform Act of 1995. The use of certain words, including \u201cbelieve,\u201d \u201cpotential,\u201d \u201cexpect\u201d and \u201cwill\u201d and similar expressions, is intended to identify forward-looking statements. Although the company believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated. These risks and uncertainties include, among other things, the uncertainties inherent in research and development, including related to safety, progression of and results from its ongoing and planned clinical trials and preclinical studies, review and approvals by regulatory authorities of its product candidates, the Company\u2019s commercialization efforts and the Company\u2019s continued ability to raise capital to fund its development. For an additional discussion of risks and uncertainties which could cause the company’s actual results, financial condition, performance or achievements to differ from those contained in the forward-looking statements, please refer to the Risk Factors (\u201cFacteurs de Risque”) section of the Universal Registration Document filed with the French Financial Markets Authority (\u201cAMF\u201d), which is available on the AMF website http:\/\/www.amf-france.org<\/a> or on Innate Pharma\u2019s website, and public filings and reports filed with the U.S. Securities and Exchange Commission (\u201cSEC\u201d), including the Company\u2019s Annual Report on Form 20-F for the year ended December 31, 2022, and subsequent filings and reports filed with the AMF or SEC, or otherwise made public, by the Company.<\/p>\n

\nThis press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to shares in Innate Pharma in any country.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20230406005537\/en\/<\/a><\/span><\/p>\n

Investors
\n<\/span><\/b>
Innate Pharma
\n<\/b>
Henry Wheeler
\n
Tel.: +33 (0)4 84 90 32 88
\n
Henry.wheeler@innate-pharma.fr<\/a><\/p>\n

Media Relations
\n<\/span><\/b>
NewCap
\n<\/b>
Arthur Rouill\u00e9
\n
Tel.: +33 (0)1 44 71 00 15
\n
innate@newcap.eu<\/a><\/p>\n

KEYWORDS:<\/b> France Europe<\/p>\n

INDUSTRY KEYWORDS:<\/b> Oncology FDA Health Clinical Trials Pharmaceutical Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023 The Annual General Meeting will be broadcasted live by the Company MARSEILLE, France–(BUSINESS WIRE)– Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (\u201cInnate\u201d or the \u201cCompany\u201d) will hold its Annual General Meeting of Shareholders (\u201cAGM\u201d) at 10:30 a.m. CEST on May 12, 2023 in its headquarters, 117 avenue de Luminy, F-13009 Marseille. The Annual General Meeting will be broadcasted live. The Notice of Meeting of this AGM was published on April 7, 2023 in the French legal bulletin. It includes the agenda, the proposed resolutions as well as instructions to participate and vote in this AGM. All documentation regarding this AGM will be published on the … <\/p>\n

Continue reading “Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-746044","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nInnate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023 The Annual General Meeting will be broadcasted live by the Company MARSEILLE, France–(BUSINESS WIRE)– Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (\u201cInnate\u201d or the \u201cCompany\u201d) will hold its Annual General Meeting of Shareholders (\u201cAGM\u201d) at 10:30 a.m. CEST on May 12, 2023 in its headquarters, 117 avenue de Luminy, F-13009 Marseille. The Annual General Meeting will be broadcasted live. The Notice of Meeting of this AGM was published on April 7, 2023 in the French legal bulletin. It includes the agenda, the proposed resolutions as well as instructions to participate and vote in this AGM. All documentation regarding this AGM will be published on the … Continue reading "Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-07T05:03:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230406005537r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023\",\"datePublished\":\"2023-04-07T05:03:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\\\/\"},\"wordCount\":769,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230406005537r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\\\/\",\"name\":\"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230406005537r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2023-04-07T05:03:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230406005537r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230406005537r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\/","og_locale":"en_US","og_type":"article","og_title":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023 - Market Newsdesk","og_description":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023 The Annual General Meeting will be broadcasted live by the Company MARSEILLE, France–(BUSINESS WIRE)– Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (\u201cInnate\u201d or the \u201cCompany\u201d) will hold its Annual General Meeting of Shareholders (\u201cAGM\u201d) at 10:30 a.m. CEST on May 12, 2023 in its headquarters, 117 avenue de Luminy, F-13009 Marseille. The Annual General Meeting will be broadcasted live. The Notice of Meeting of this AGM was published on April 7, 2023 in the French legal bulletin. It includes the agenda, the proposed resolutions as well as instructions to participate and vote in this AGM. All documentation regarding this AGM will be published on the … Continue reading \"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-07T05:03:04+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230406005537r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023","datePublished":"2023-04-07T05:03:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\/"},"wordCount":769,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230406005537r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\/","name":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230406005537r1&sid=flmnd&distro=nx&lang=en","datePublished":"2023-04-07T05:03:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230406005537r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230406005537r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-12-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/746044","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=746044"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/746044\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=746044"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=746044"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=746044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}